Effectiveness of combined use of mifepristone and misoprostol in comparison to misoprostol alone in induction of labor in intrauterine fetal death
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254273Keywords:
Efficacy, Intrauterine fetal death, Labor induction, Mifepristone, Misoprostol, Randomized controlled trial, SafetyAbstract
Background: Intrauterine fetal death (IUFD) remains a significant obstetric challenge, with a global prevalence of 1-4% of pregnancies. Timely and effective induction of labor is critical to minimizing complications like coagulopathy and infection. Prostaglandins, especially misoprostol, are widely used for labor induction. This study compared the efficacy and safety of the combined regimen of mifepristone and misoprostol in comparison to misoprostol alone in IUFD management.
Methods: This randomized controlled trial was conducted in the department of obstetrics and gynecology, Institute of Child and Mother Health (ICMH), Matuail, Dhaka, from October 2023 to March 2025. A total of 68 patients with intrauterine fetal death (IUFD) requiring induction of labor were enrolled.
Results: The induction to labour interval was significantly shorter in group A (6.32±2.16 hours) compared to group B (16.06±5.59 hours) p=0.00. The induction-to-delivery interval was significantly shorter in group A (13.88±5.36 hours) compared to group B (26.62 ±11.86 hours, p=0.00). The mean dose of misoprostol was lower in group A (2.85±0.61) versus group B (3.97±0.30, p<0.001). Group A demonstrated fewer side effects like fever which was statistically significant (p-0.008). Other side effects like diarrhoea vomiting headache were not statistically significant. There were no statistically significant differences in the observed complication like PPH retained placenta hyperstimulation gastrointestinal symptoms in both groups. Group A also demonstrated shorter hospital stay (4.71±0.63 versus 5.21±0.77 days, p=0.005).
Conclusions: Combined mifepristone and misoprostol therapy is more effective and safer than misoprostol alone for labor induction in intrauterine fetal death.
References
Modak R, Roy S, Biswas DK, Pal A, Mandal TK. Role of combination of mifepristone and misoprostol versus misoprostol alone in induction of labor in late intrauterine fetal death: a randomized trial. Int J Clin Obstet Gynecol. 2018;2(6):78-82.
Belani D, Kaur J, Kaur A, Rani M, Sehgal C, Maji A. A comparative study of misoprostol alone versus (vs) mifepristone and misoprostol for induction of labor in intrauterine fetal death (IUFD). Int J Acad Med Pharm. 2023;5(1):534-7.
Moond S, Banerjee KP, Arya R. A comparative study of mifepristone and misoprostol versus misoprostol alone in induction of labour in late intrauterine fetal death. Int J Med Biomed Stud. 2021;5(2).
Talasani S, Venkamolla PH, Betha K. Comparison between use of combination of mifepristone and misoprostol versus misoprostol alone in the management of intrauterine fetal death. Int J Reprod Contracept Obstet Gynecol. 2018;7(7):2779.
Sharma D, Singhal SR, Poonam, Paul A, Kunika. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death. Taiwan J Obstet Gynecol. 2011;50(3):322-5.
Ahuja N, Dahiya P. A comparative study of mifepristone alone versus mifepristone and misoprostol for induction of labor in intrauterine fetal death. Indian J Obstet Gynecol Res. 2016;3(4):348-51.
Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG. 2002;109(4):443-7.
Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy. J Obstet Gynecol India. 2011;61(6):659-62.
Abbasi S, Siddiqua SF, Alam MNA, Jesmin S, Siddiqui MMR, Rahman MT. Role of combined mifepristone and misoprostol verses misoprostol alone in induction of labour in patients with intrauterine foetal death - a randomized comparison between their outcome. Anwer Khan Modern Med Coll J. 2017;8(1):50-4.
Väyrynen W, Heikinheimo O, Nuutila M. Misoprostol‐only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death. Acta Obstet Gynecol Scand. 2007;86(6):701-5.
Trivedi K, Swati A, Shrivastava P, Singh S. Mifepristone followed by prostaglandin versus prostaglandin alone for induction of labour in intrauterine foetal death at or more than 28 weeks of pregnancy. Int J Contemp Med Res. 2019;6(10).
Panda S, Jha V, Singh S. Role of combination of mifepristone and misoprostol verses misoprostol alone in induction of labour in late intrauterin fetal death: a prospective study. J Fam Reprod Health. 2013;7(4):177-9.
Islam S, Mostafa J, Akter M. Effectiveness and safety of mifepristone: misoprotole combination versus misoprostole alone for induction of labour in intrauterine foetal death’, 2024;8(5):98-104.
Hemalatha KR, Mulla QK. Comparative study of mifepristone and misoprostol versus misoprostol alone in induction of labour in late intrauterine fetal death. Int J Reprod Contracept Obstet Gynecol. 2018;7(3):987-91.
Gupta S, Kagathra B, Desai A. Mifepristone and misoprostol versus misoprostol alone in management of late intrauterine fetal death. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):2935-8.
Directorate General of Health Services. Maternal and Perinatal Death Surveillance and Response (MPDSR) in Bangladesh: Progress and Highlights in 2023. Available from: https://reliefweb.int/report/ bangladesh/maternal-and-perinatal-death-surveillance-and-response-mpdsr-bangladesh-progress-and-highlights-2023. Accessed on 6 July 2025.
Shaw KA, Topp NJ, Shaw JG, Blumenthal PD. Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review. Obstet Gynecol. 2013;121(6):1335-47.
Downloads
Published
How to Cite
Issue
Section
